A PIPELINE POWERED BYPASSION
PUBLICATIONS AND PRESENTATIONS
Discovery of CK-274: A novel, small molecule, cardiac myosin inhibitor for the treatment of hypertrophic cardiomyopathies (HCM)
Presentation, American Chemical Society (ACS) Spring Meeting 2021
Virtual
April 9, 2021
Impact of Patient Characteristics on Effect Size in FORTITUDE-ALS
Poster, 31st International Symposium on ALS/MND
Virtual
December 11, 2020
People Living with ALS and Their Caregivers’ Input into Drug Development in Europe
Poster, 31st International Symposium on ALS/MND
Virtual
December 11, 2020
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Reldesemtiv in Patients with Amyotrophic Lateral Sclerosis (ALS): COURAGE-ALS Trial Design
Poster, 31st International Symposium on ALS/MND
Virtual
December 11, 2020
Thirty-Day Episode of Care Spending Following Heart Failure Hospitalization Among Medicare Beneficiaries with Heart Failure
Poster, American Heart Association (AHA) Scientific Sessions 2020
Virtual
November 16, 2020